documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
6 rows where docket_id = "FDA-2002-E-0120" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2002-E-0120-0006 | FDA | Patent Application for Dutrasteride FDA-2002-E-0120 | Letter from U.S. Patent and Trademark Office to GlaxoSmithKline | Rule | Certificate Extending Patent Term | 2007-04-23T04:00:00Z | 2007 | 4 | 2025-10-02T20:00:05Z | 0 | 0 | 0900006480490324 | |||
| FDA-2002-E-0120-0005 | FDA | Patent Application for Dutrasteride FDA-2002-E-0120 | Notice of Final Determination | Other | Letter(s) | 2007-02-06T05:00:00Z | 2007 | 2 | 2025-10-02T19:57:57Z | 0 | 0 | 0900006480490323 | |||
| FDA-2002-E-0120-0004 | FDA | Patent Application for Dutrasteride FDA-2002-E-0120 | Letter from FDA CDER to U.S. Patent and Trademark Office | Other | Letter(s) | 2007-01-10T05:00:00Z | 2007 | 1 | 2025-10-02T19:54:42Z | 0 | 0 | 0900006480490322 | |||
| FDA-2002-E-0120-0003 | FDA | Patent Application for Dutrasteride FDA-2002-E-0120 | Determination of Regulatory Review Period for Purposes of Patent Extension; DUTASTERIDE | Notice | General Notice | 2006-06-14T04:00:00Z | 2006 | 6 | 2006-06-14T04:00:00Z | 2025-10-02T19:51:44Z | E6-9224 | 0 | 0 | 0900006480490321 | |
| FDA-2002-E-0120-0002 | FDA | Patent Application for Dutrasteride FDA-2002-E-0120 | Letter from FDA CDER to U.S. Patent and Trademark Office | Other | Letter(s) | 2006-05-25T04:00:00Z | 2006 | 5 | 2025-10-02T19:33:29Z | 0 | 0 | 0900006480490320 | |||
| FDA-2002-E-0120-0001 | FDA | Patent Application for Dutrasteride FDA-2002-E-0120 | Letter from U.S. Patent and Trademark Office to FDA CDER | Other | Letter(s) | 2006-05-25T04:00:00Z | 2006 | 5 | 2025-10-02T19:31:09Z | 0 | 0 | 09000064804902d6 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);